BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15935888)

  • 21. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children.
    Stastny P; Lavingia B; Fixler DE; Yancy CW; Ring WS
    Transplantation; 2007 Sep; 84(6):738-45. PubMed ID: 17893607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies.
    Cherry R; Nielsen H; Reed E; Reemtsma K; Suciu-Foca N; Marboe CC
    J Heart Lung Transplant; 1992; 11(1 Pt 1):24-9; discussion 30. PubMed ID: 1540608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between the presence of anti-HLA antibodies with acute rejection and chronic allograft nephropathy in the first year after kidney transplantation.
    Toresan R; Manfro RC; Proença MC; Veronese FJ; Salim PH; da Silva DM; Ribeiro AR; Edelweiss MI; Pegas KL; Jobim LF
    Transplant Proc; 2008 Apr; 40(3):718-9. PubMed ID: 18454996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human leukocyte antigen sensitization in ventricular assist device recipients: a lesser risk with the DeBakey axial pump.
    Grinda JM; Bricourt MO; Amrein C; Salvi S; Guillemain R; Francois A; Guibourt P; Deloche A; Fabiani JN
    Ann Thorac Surg; 2005 Sep; 80(3):945-8. PubMed ID: 16122460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-HLA antibodies in heart transplantation.
    Vasilescu ER; Ho EK; de la Torre L; Itescu S; Marboe C; Cortesini R; Suciu-Foca N; Mancini D
    Transpl Immunol; 2004 Jan; 12(2):177-83. PubMed ID: 14967316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation.
    Petrossian GA; Nichols AB; Marboe CC; Sciacca R; Rose EA; Smith CR; Cannon PJ; Reemtsma K; Powers ER
    Circulation; 1989 Nov; 80(5 Pt 2):III122-5. PubMed ID: 2805291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database.
    Rossano JW; Morales DL; Zafar F; Denfield SW; Kim JJ; Jefferies JL; Dreyer WJ
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):694-9, 699.e1-2. PubMed ID: 20537356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S
    Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
    Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
    J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloantibodies in heart transplantation.
    Ho EK; Vlad G; Colovai AI; Vasilescu ER; Schwartz J; Sondermeijer H; Burke E; Marboe CC; Itescu S; Suciu-Foca N; Mancini D
    Hum Immunol; 2009 Oct; 70(10):825-9. PubMed ID: 19555730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V; Venetz JP; Pantaleo G; Pascual M
    Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HLA antibodies in kidney transplanted patients.
    Maccarone D; Cervelli C; Parzanese I; Pisani F; Caniglia L; Rascente M; Battistoni C; Famulari A; Adorno D
    Transplant Proc; 2005; 37(6):2459-60. PubMed ID: 16182708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.